Riboflavin, MTHFR genotype and blood pressure: A personalized approach to prevention and treatment of hypertension
Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research
GLP-1 medications work by enhancing insulin secretion, suppressing glucagon, delaying gastric emptying, and regulating appetite through glucose-dependent mechanisms
Injecting cold medication directly from the refrigerator is a common cause of injection site discomfort and can trigger localised reactions
Although patients at risk for diabetes (ie, prediabetes, defined as a hemoglobin A1C 5.7% to 6.4% or a fasting blood glucose level 100 to 125 mg/dL) were included in FDA registration trials of Saxenda or Wegovy, prediabetes is not an FDA indication for any GLP-1 agonist
Despite its impressive TRIUMPH-1 results, this groundbreaking medication must clear further regulatory hurdles before reaching patients